Mikiel Calleja is a senior associate in the corporate and finance practice of the firm. Mikiel’s main practice areas are mergers and acquisitions, capital markets, corporate finance and general corporate/commercial. As counsel to financial institutions and public and private companies, he has significant experience in corporate transactions and financing including local and cross border mergers, acquisitions and restructuring, related financing and security arrangements, private and public offerings of securities and often advises public companies on regulatory requirements. Mikiel is also regularly involved in various corporate and company law matters and has both assisted and managed in vendor and purchaser related legal due diligence.

Mikiel has recently also had a paper entitled “Piercing the Corporate Veil: Greening Companies’ Governance and Shareholder Activism” published in the peer reviewed IUCN Academy of Environmental Law Journal.

Malta: Bill for the Production of Cannabis for Medicinal Use

Malta: Bill for the Production of Cannabis for Medicinal Use
Malta: Bill for the Production of Cannabis for Medicinal Use Production of Cannabis for Medicinal Use Act, 2018On the 15 January 2018 a Bill was introduced by the Honourable Chris Cardona, M.P., Minister for the Economy, Investment and Small Businesses, to permit the local industrial production of cannabis products for medical use in the context of a controlled and supervised environment.Definition of Cannabis and Licence Requirement"Cannabis" is defined as "fresh or dried cannabis, cannabis oil, cannabis plant or seeds, derivatives of cannabis, and/or any substan...
Continue reading

New Prospectus Regulation: Easier Access to Capital Markets

New Prospectus Regulation: Easier Access to Capital Markets
On 16 May 2017, the Council adopted new rules on prospectuses for the issuing and offering of securities. The new prospectus regulation ("PR3") will repeal and replace the Prospectus Directive (2003/71/EC) and the existing Prospectus Regulation (809/2004). Unlike directives, regulations do not require further implementation measures by EU member states to be effective. The main aim of PR3 is to facilitate access to financial markets for companies, particularly small and medium-sized enterprises through the simplification of the rules and streamlining of related ad...
Continue reading

Archive

2016
January
February
March
April
June
August
September
October
2015
January
February
March
April
June
July
August
September
October
November
December
2014
January
February
April
May
June
July
August
September
October
November
December
2013
January
February
March
April
May
June
July
August
September
October
December